Nat Med. 2006 Feb;12(2):190-7. Epub 2006 Feb 5.

A T-cell HCV vaccine eliciting effective immunity against heterologous virus challenge in chimpanzees.

Folgori A, Capone S, Ruggeri L, Meola A, Sporeno E, Ercole BB, Pezzanera M, Tafi R, Arcuri M, Fattori E, Lahm A, Luzzago A, Vitelli A, Colloca S, Cortese R, Nicosia A.

Source

Istituto di Ricerche di Biologia Molecolare P. Angeletti, via Pontina km30,600, 00040 Pomezia, Rome, Italy.

Abstract

Three percent of the world's population is chronically infected with the hepatitis C virus (HCV) and at risk of developing liver cancer. Effective cellular immune responses are deemed essential for spontaneous resolution of acute hepatitis C and long-term protection. Here we describe a new T-cell HCV genetic vaccine capable of protecting chimpanzees from acute hepatitis induced by challenge with heterologous virus. Suppression of acute viremia in vaccinated chimpanzees occurred as a result of massive expansion of peripheral and intrahepatic HCV-specific CD8(+) T lymphocytes that cross-reacted with vaccine and virus epitopes. These findings show that it is possible to elicit effective immunity against heterologous HCV strains by stimulating only the cellular arm of the immune system, and suggest a path for new immunotherapy against highly variable human pathogens like HCV, HIV or malaria, which can evade humoral responses.

Comment in

Gastroenterology. 2007 Apr;132(4):1626-8.

PMID:: 16462801; [PubMed - indexed for MEDLINE]

LinkOut - more resources

Full Text Sources

Supplemental Content

Save items

Related citations in PubMed

Review Hepatitis C vaccines: Inducing and challenging memory T cells. [Hepatology. 2006]
Review Hepatitis C vaccines: Inducing and challenging memory T cells.
Shiina M, Rehermann B. Hepatology. 2006 Jun; 43(6):1395-8.
Hepatitis C virus continuously escapes from neutralizing antibody and T-cell responses during chronic infection in vivo. [Gastroenterology. 2007]
Hepatitis C virus continuously escapes from neutralizing antibody and T-cell responses during chronic infection in vivo.
von Hahn T, Yoon JC, Alter H, Rice CM, Rehermann B, Balfe P, McKeating JA. Gastroenterology. 2007 Feb; 132(2):667-78. Epub 2006 Dec 3.
Immunization with hepatitis C virus-like particles results in control of hepatitis C virus infection in chimpanzees. [Proc Natl Acad Sci U S A. 2007]
Immunization with hepatitis C virus-like particles results in control of hepatitis C virus infection in chimpanzees.
Elmowalid GA, Qiao M, Jeong SH, Borg BB, Baumert TF, Sapp RK, Hu Z, Murthy K, Liang TJ. Proc Natl Acad Sci U S A. 2007 May 15; 104(20):8427-32. Epub 2007 May 7.
Control of heterologous hepatitis C virus infection in chimpanzees is associated with the quality of vaccine-induced peripheral T-helper immune response. [J Virol. 2004]
Control of heterologous hepatitis C virus infection in chimpanzees is associated with the quality of vaccine-induced peripheral T-helper immune response.
Rollier C, Depla E, Drexhage JA, Verschoor EJ, Verstrepen BE, Fatmi A, Brinster C, Fournillier A, Whelan JA, Whelan M, et al. J Virol. 2004 Jan; 78(1):187-96.
Review Cell-mediated immunity and the outcome of hepatitis C virus infection. [Annu Rev Microbiol. 2004]
Review Cell-mediated immunity and the outcome of hepatitis C virus infection.
Shoukry NH, Cawthon AG, Walker CM. Annu Rev Microbiol. 2004; 58:391-424.

See reviews... See all...

Cited by 27 PubMed Central articles

Naturally occurring antibodies that recognize linear epitopes in the amino terminus of the hepatitis C virus E2 protein confer noninterfering, additive neutralization. [J Virol. 2012]
Naturally occurring antibodies that recognize linear epitopes in the amino terminus of the hepatitis C virus E2 protein confer noninterfering, additive neutralization.
Tarr AW, Urbanowicz RA, Jayaraj D, Brown RJ, McKeating JA, Irving WL, Ball JK. J Virol. 2012 Mar; 86(5):2739-49. Epub 2011 Dec 14.
Effect of route of delivery on heterologous protection against HCV induced by an adenovirus vector carrying HCV structural genes. [Virol J. 2011]
Effect of route of delivery on heterologous protection against HCV induced by an adenovirus vector carrying HCV structural genes.
Guan J, Wen B, Deng Y, Zhang K, Chen H, Wu X, Ruan L, Tan W. Virol J. 2011 Nov 4; 8:506. Epub 2011 Nov 4.
HCV animal models: a journey of more than 30 years. [Viruses. 2009]
HCV animal models: a journey of more than 30 years.
Meuleman P, Leroux-Roels G. Viruses. 2009 Sep; 1(2):222-40. Epub 2009 Sep 2.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.
Cited in Books
NCBI Bookshelf books that cite the current articles.

Recent activity

Clear Turn Off Turn On

A T-cell HCV vaccine eliciting effective immunity against heterologous virus cha...
A T-cell HCV vaccine eliciting effective immunity against heterologous virus challenge in chimpanzees.
Nat Med. 2006 Feb ;12(2):190-7. Epub 2006 Feb 5 .

PubMed
Latent human herpesvirus 6 infection of human monocytes/macrophages.
Latent human herpesvirus 6 infection of human monocytes/macrophages.
J Gen Virol. 1991 Jun ;72 ( Pt 6):1401-8.

PubMed
A microRNA expression signature of human solid tumors defines cancer gene target...
A microRNA expression signature of human solid tumors defines cancer gene targets.
Proc Natl Acad Sci U S A. 2006 Feb 14 ;103(7):2257-61. Epub 2006 Feb 3 .

PubMed
Hypercalcemia and production of parathyroid hormone-like protein in adult T-cell...
Hypercalcemia and production of parathyroid hormone-like protein in adult T-cell leukemia-lymphoma.
Eur J Haematol. 1992 May ;48(5):278-9.

PubMed
Sustained control of viremia following therapeutic immunization in chronically H...
Sustained control of viremia following therapeutic immunization in chronically HIV-1-infected individuals.
AIDS. 2006 Feb 14 ;20(3):405-13.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

A T-cell HCV vaccine eliciting effective immunity against heterologous virus challenge in chimpanzees.

Source

Abstract

Comment in

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Molecular Biology Databases

Libraries

Supplemental Content

Save items

Related citations in PubMed

Cited by 27 PubMed Central articles

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information